APA (7th ed.) Citation

T, L., T, J., X, Y., C, L., J, S., Z, N., . . . Y, Y. (2016). Development of octreotide-conjugated polymeric prodrug of bufalin for targeted delivery to somatostatin receptor 2 overexpressing breast cancer in vitro and in vivo. Dove Medical Press.

Chicago Style (17th ed.) Citation

T, Liu, Jia T, Yuan X, Liu C, Sun J, Ni Z, Xu J, Wang X, and Yuan Y. Development of Octreotide-conjugated Polymeric Prodrug of Bufalin for Targeted Delivery to Somatostatin Receptor 2 Overexpressing Breast Cancer in Vitro and in Vivo. Dove Medical Press, 2016.

MLA (8th ed.) Citation

T, Liu, et al. Development of Octreotide-conjugated Polymeric Prodrug of Bufalin for Targeted Delivery to Somatostatin Receptor 2 Overexpressing Breast Cancer in Vitro and in Vivo. Dove Medical Press, 2016.